Plain-English translation of NCT06382051 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether an improved version of a screening questionnaire — called PEST+pictures+2 — can better detect psoriatic arthritis (a condition where the joints become inflamed) in people with moderate-to-severe plaque psoriasis. The new version adds two extra questions about morning stiffness and nighttime back pain, plus pictures of swollen joints and nails to help patients recognize symptoms they might have missed. Researchers want to see if this improved tool catches more cases of joint disease early, so patients can get treatment sooner.
Many people with plaque psoriasis also develop joint problems, but these cases often go undetected because patients and doctors don't always recognize the early signs. By testing a better screening tool, researchers hope to identify more patients who need treatment before joint damage occurs.
You likely qualify if…
You likely don't qualify if…
You will visit your dermatologist, where you'll answer a short screening questionnaire (with pictures included) to check for signs of joint disease — this takes place during your regular appointment. If your answers suggest you might have joint problems, you'll have a second visit with a rheumatologist who will do a full evaluation. About 4 months later, you'll have a final check-in (which can be remote) with your dermatologist to document what treatment you've chosen. The entire study lasts up to 120 days.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Canada